JP2025506248A5 - - Google Patents

Info

Publication number
JP2025506248A5
JP2025506248A5 JP2024548730A JP2024548730A JP2025506248A5 JP 2025506248 A5 JP2025506248 A5 JP 2025506248A5 JP 2024548730 A JP2024548730 A JP 2024548730A JP 2024548730 A JP2024548730 A JP 2024548730A JP 2025506248 A5 JP2025506248 A5 JP 2025506248A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024548730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/077493 external-priority patent/WO2023155925A1/en
Publication of JP2025506248A publication Critical patent/JP2025506248A/ja
Publication of JP2025506248A5 publication Critical patent/JP2025506248A5/ja
Priority to JP2026041936A priority Critical patent/JP2026088290A/ja
Pending legal-status Critical Current

Links

JP2024548730A 2022-02-21 2023-02-21 抗5t4抗体およびその使用 Pending JP2025506248A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026041936A JP2026088290A (ja) 2022-02-21 2026-03-16 抗5t4抗体およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2022077113 2022-02-21
CNPCT/CN2022/077113 2022-02-21
PCT/CN2023/077493 WO2023155925A1 (en) 2022-02-21 2023-02-21 Anti-5t4 antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026041936A Division JP2026088290A (ja) 2022-02-21 2026-03-16 抗5t4抗体およびその使用

Publications (2)

Publication Number Publication Date
JP2025506248A JP2025506248A (ja) 2025-03-07
JP2025506248A5 true JP2025506248A5 (cg-RX-API-DMAC7.html) 2026-01-22

Family

ID=87577641

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024548730A Pending JP2025506248A (ja) 2022-02-21 2023-02-21 抗5t4抗体およびその使用
JP2026041936A Pending JP2026088290A (ja) 2022-02-21 2026-03-16 抗5t4抗体およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026041936A Pending JP2026088290A (ja) 2022-02-21 2026-03-16 抗5t4抗体およびその使用

Country Status (8)

Country Link
US (1) US20250154277A1 (cg-RX-API-DMAC7.html)
EP (2) EP4482876A1 (cg-RX-API-DMAC7.html)
JP (2) JP2025506248A (cg-RX-API-DMAC7.html)
KR (2) KR20250004629A (cg-RX-API-DMAC7.html)
CN (2) CN118946590A (cg-RX-API-DMAC7.html)
AU (2) AU2023220523A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250452A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023155925A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026010986A1 (en) * 2024-07-05 2026-01-08 Solve Therapeutics, Inc. 5t4-binding proteins
CN119192356B (zh) * 2024-09-29 2025-05-27 华中农业大学 识别犬瘟热病毒h蛋白的单克隆抗体、检测试纸条及应用
WO2026096278A1 (en) * 2024-10-29 2026-05-07 Mayo Foundation For Medical Education And Research Molecules that bind to b7 homolog 3 polypeptides

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
US6420140B1 (en) 1996-10-11 2002-07-16 Abgenix, Inc. Production of multimeric protein by cell fusion method
CA2578131A1 (en) * 2004-09-10 2006-03-23 Wyeth Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates
SG170091A1 (en) * 2006-03-10 2011-04-29 Wyeth Corp Anti-5t4 antibodies and uses thereof
HUE031017T2 (en) * 2011-04-01 2017-06-28 Wyeth Llc Antibody Drug Conjugates
WO2014137931A1 (en) * 2013-03-06 2014-09-12 Imaginab, Inc. Antigen binding constructs to 5t4
KR20180083425A (ko) * 2015-11-24 2018-07-20 신톤 바이오파머슈티칼즈 비.브이. 항-5t4 항체 및 항체-약물 접합체
CN108285487B (zh) * 2017-01-08 2021-02-19 浙江昭华生物医药有限公司 抗5t4抗体-药物偶联物及其应用

Similar Documents

Publication Publication Date Title
JP7763230B2 (ja) Cd47に対するヒト化及びキメラモノクローナル抗体
CN112646031B (zh) 抗4-1bb纳米抗体及其用途
JP2023511774A5 (cg-RX-API-DMAC7.html)
AU2026200768A1 (en) Tem8 antibodies and their use
AU2011336650B2 (en) Chimeric rabbit/human ROR1 antibodies
IL268745A (en) Antibody drug conjugates (adc) that bind to 158p1d7 proteins
JP2022101693A5 (cg-RX-API-DMAC7.html)
JP2023549537A5 (cg-RX-API-DMAC7.html)
JP2011501656A5 (cg-RX-API-DMAC7.html)
JP2024501894A5 (cg-RX-API-DMAC7.html)
JP2011509245A5 (cg-RX-API-DMAC7.html)
JP2022513420A5 (cg-RX-API-DMAC7.html)
JP2022553922A5 (cg-RX-API-DMAC7.html)
CN115427449A (zh) 抗Gal3抗体和使用方法
JP2024537323A5 (cg-RX-API-DMAC7.html)
JP2014524902A5 (cg-RX-API-DMAC7.html)
TWI845724B (zh) 用於偶聯的多肽複合物及其應用
JP2020500834A5 (cg-RX-API-DMAC7.html)
JP2019507580A5 (cg-RX-API-DMAC7.html)
JP2024532489A5 (cg-RX-API-DMAC7.html)
JP2023548529A5 (cg-RX-API-DMAC7.html)
JP2019505166A5 (cg-RX-API-DMAC7.html)
JP2022512647A5 (cg-RX-API-DMAC7.html)
WO2022135441A1 (zh) 抗il-4r抗体或其抗原结合片段的复合物及医药用途
CA2508519A1 (en) Recombinant immunotoxin and use in treating tumors